Chugai Pharmaceutical Co (TSE:4519) Market Cap : 円11,724,940 Mil (As of Jul. 04, 2025)

View and export this data going back to 1956. Start your Free Trial

What is Chugai Pharmaceutical Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Chugai Pharmaceutical Co's share price for the quarter that ended in Mar. 2025 was 円6799. Chugai Pharmaceutical Co's Shares Outstanding (EOP) for the quarter that ended in Mar. 2025 was 1,646 Mil. Therefore, Chugai Pharmaceutical Co's market cap for the quarter that ended in Mar. 2025 was 円11,187,931 Mil.

Chugai Pharmaceutical Co's quarterly market cap increased from Sep. 2024 (円11,406,703 Mil) to Dec. 2024 (円11,517,036 Mil) but then declined from Dec. 2024 (円11,517,036 Mil) to Mar. 2025 (円11,187,931 Mil).

Chugai Pharmaceutical Co's annual market cap increased from Dec. 2022 (円5,538,063 Mil) to Dec. 2023 (円8,789,267 Mil) and increased from Dec. 2023 (円8,789,267 Mil) to Dec. 2024 (円11,517,036 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Chugai Pharmaceutical Co's Enterprise Value for Today is 円10,780,390 Mil.

Chugai Pharmaceutical Co Market Cap Historical Data

The historical data trend for Chugai Pharmaceutical Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chugai Pharmaceutical Co Market Cap Chart

Chugai Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Market Cap

Get a 7-Day Free Trial

9,046,222.11

6,141,527.73

5,538,063.02

8,789,267.39

11,517,036.47

Chugai Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Market Cap	Get a 7-Day Free Trial															9,483,981.85	9,405,512.24	11,406,703.05	11,517,036.47	11,187,931.27

Competitive Comparison of Chugai Pharmaceutical Co's Market Cap

For the Drug Manufacturers - General subindustry, Chugai Pharmaceutical Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chugai Pharmaceutical Co's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chugai Pharmaceutical Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Chugai Pharmaceutical Co's Market Cap falls into.

Save Embed

;

Save Embed

;

Chugai Pharmaceutical Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Chugai Pharmaceutical Co's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as

Market Cap (A: Dec. 2024 )	=	Share Price (A: Dec. 2024 )	*	Shares Outstanding (EOP) (A: Dec. 2024 )
	=	円6999	*	1645.526
	=	円11,517,036

Chugai Pharmaceutical Co's Market Cap for the quarter that ended in Mar. 2025 is calculated as

Market Cap (Q: Mar. 2025 )	=	Share Price (Q: Mar. 2025 )	*	Shares Outstanding (EOP) (Q: Mar. 2025 )
	=	円6799	*	1645.526
	=	円11,187,931

Chugai Pharmaceutical Co (TSE:4519) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Chugai Pharmaceutical Co Market Cap Related Terms

Thank you for viewing the detailed overview of Chugai Pharmaceutical Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Chugai Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chugai Pharmaceutical Co Ltd (TSE:4519) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

CHGCY:USA CHGCF:USA 4519N:Mexico CUP:Germany

Address

1-1 Nihonbashi-Muromachi 2-Chome, Nihonbashi Mitsui Tower (Reception15F), Chuo-ku, Tokyo, JPN, 103-8324

Website

http://www.chugai-pharm.co.jp

Chugai Pharmaceutical is a Japanese drug developer and subsidiary of Roche Holding, which owns roughly 60% of the company. Founded in 1925, Chugai deals primarily in the Japanese market, where it generates roughly half of its revenue. It has been the leader in Japan's oncology market for the past decade, largely due to drugs licensed from its parent's portfolio. The company also develops its own innovative medicines. It is an industry leader in antibody technology with several flagship therapies, including Hemlibra for hemophilia A patients and Actemra for treating rheumatoid arthritis and covid patients.

Chugai Pharmaceutical Co Headlines

No Headlines